Otsuka Holdings Co., Ltd. (4578.T)

JPY 8530.0

(-0.92%)

Operating Expenses Summary of Otsuka Holdings Co., Ltd.

  • Otsuka Holdings Co., Ltd.'s latest annual operating expenses in 2023 was 1115.15 Billion JPY , up 13.51% from previous year.
  • Otsuka Holdings Co., Ltd.'s latest quarterly operating expenses in 2024 Q3 was 317.52 Billion JPY , up 1.92% from previous quarter.
  • Otsuka Holdings Co., Ltd. reported a annual operating expenses of 982.43 Billion JPY in annual operating expenses 2022, up 15.47% from previous year.
  • Otsuka Holdings Co., Ltd. reported a annual operating expenses of 850.77 Billion JPY in annual operating expenses 2021, up 10.28% from previous year.
  • Otsuka Holdings Co., Ltd. reported a quarterly operating expenses of 311.53 Billion JPY for 2024 Q2, up 8.88% from previous quarter.
  • Otsuka Holdings Co., Ltd. reported a quarterly operating expenses of 286.13 Billion JPY for 2024 Q1, down -11.36% from previous quarter.

Annual Operating Expenses Chart of Otsuka Holdings Co., Ltd. (2023 - 2008)

Historical Annual Operating Expenses of Otsuka Holdings Co., Ltd. (2023 - 2008)

Year Operating Expenses Operating Expenses Growth
2023 1115.15 Billion JPY 13.51%
2022 982.43 Billion JPY 15.47%
2021 850.77 Billion JPY 10.28%
2020 771.47 Billion JPY 0.13%
2019 770.5 Billion JPY 1.6%
2018 758.36 Billion JPY 3.52%
2017 732.6 Billion JPY 4.06%
2016 704.04 Billion JPY -16.59%
2015 844.11 Billion JPY -8.72%
2014 924.77 Billion JPY 13.83%
2013 812.41 Billion JPY 24.12%
2012 654.56 Billion JPY 44.55%
2011 452.82 Billion JPY 1.36%
2010 446.73 Billion JPY -4.17%
2009 466.17 Billion JPY 17.97%
2008 395.15 Billion JPY 0.0%

Peer Operating Expenses Comparison of Otsuka Holdings Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Kyowa Kirin Co., Ltd. 224.77 Billion JPY -396.114%
Astellas Pharma Inc. 1034.29 Billion JPY -7.818%
Chugai Pharmaceutical Co., Ltd. 258.88 Billion JPY -330.751%
Ono Pharmaceutical Co., Ltd. 212.44 Billion JPY -424.922%
Santen Pharmaceutical Co., Ltd. 111.97 Billion JPY -895.918%
JCR Pharmaceuticals Co., Ltd. 23.72 Billion JPY -4601.345%
Daiichi Sankyo Company, Limited 974.77 Billion JPY -14.401%
Perseus Proteomics Inc. 982.41 Million JPY -113412.124%